These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 125655)

  • 1. Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
    Christian ST; McClain LD; Morin RD; Benington F
    Experientia; 1975 Aug; 31(8):910-11. PubMed ID: 125655
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).
    Dyer DC; Benington F; Morin RD
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):197-200. PubMed ID: 127560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 4. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM; Rousselle JC; Fillion MP; Beaudoin DM; Goiny MR; Deniau JM; Jacob JJ
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract]   [Full Text] [Related]  

  • 5. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G; Fillion MP; Rousselle JC; Beaudoin D; Goiny M; Jacob J
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):979-81. PubMed ID: 405135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
    Farrow JT; Van Vunakis H
    Biochem Pharmacol; 1973 May; 22(9):1103-13. PubMed ID: 4695669
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.
    Mehl E; Rüther E; Redemann J
    Psychopharmacology (Berl); 1977 Aug; 54(1):9-16. PubMed ID: 410064
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of d-lysergic acid diethylamide to subcellular fractions from rat brain.
    Farrow JT; Van Vunakis H
    Nature; 1972 May; 237(5351):164-6. PubMed ID: 4555508
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of LSD-displacing factors and multiple types of high affinity LSD-binding sites.
    Stolzki B; Kaiser HO; Mehl EL
    Life Sci; 1978 Aug; 23(6):593-7. PubMed ID: 692283
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Hydroxytryptamine binding to synaptic membranes from rat brain.
    Fillion G; Fillion MP; Spirakis C; Bahers JM; Jacob J
    Life Sci; 1976 Jan; 18(1):65-74. PubMed ID: 2829
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo 3H-d-LSD binding in small punched out rat brain regions.
    Kräuchi K; Feer H
    Experientia; 1980 Sep; 36(9):1094-5. PubMed ID: 7418848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.
    Hetey L; Quiring K
    Acta Biol Med Ger; 1980; 39(8-9):889-95. PubMed ID: 7282218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
    Christian ST; Harrison R; Quayle E; Pagel J; Monti J
    Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
    [No Abstract]   [Full Text] [Related]  

  • 16. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of LSD and 5-methoxy-N,N-dimethyltryptamine on the high affinity uptake of [3H]-serotonin by isolated rat brain synaptosomes].
    Uebelhack R; Franke L; Seidel K
    Acta Biol Med Ger; 1978; 37(10):1611-4. PubMed ID: 752213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of specific binding sites labeled by [3H]LSD in coronal sections of paraformaldehyde-fixed rat brain.
    Beck SG; Azmitia EC
    Brain Res; 1985 Oct; 345(2):369-73. PubMed ID: 4041897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 20. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL; Lien EJ; Shih JC
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.